These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17361331)

  • 41. Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide.
    Hochhauser D; Kotecha M; O'hare C; Morris PJ; Hartley JM; Taherbhai Z; Harris D; Forni C; Mantovani R; Lee M; Hartley JA
    Mol Cancer Ther; 2007 Jan; 6(1):346-54. PubMed ID: 17237293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
    Kusumoto H; Rodgers QE; Boege F; Raimondi SC; Beck WT
    Cancer Res; 1996 Jun; 56(11):2573-83. PubMed ID: 8653700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.
    Zhao H; Yu H; Liu Y; Wang Y; Cai W
    Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance.
    Lage H; Helmbach H; Dietel M; Schadendorf D
    Br J Cancer; 2000 Jan; 82(2):488-91. PubMed ID: 10646909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
    Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
    Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Etoposide-induced DNA strand breaks in relation to p-glycoprotein and topoisomerase II protein expression in leukaemic cells from patients with AML and CLL.
    Zhou R; Vitols S; Gruber A; Liliemark J; Wang Y; Liliemark E
    Br J Haematol; 1999 May; 105(2):420-7. PubMed ID: 10233413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer.
    Naniwa J; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Shimogai R; Kawaguchi W; Sato S; Terakawa N
    Int J Gynecol Cancer; 2007; 17(1):76-82. PubMed ID: 17291235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etoposide targets topoisomerase IIalpha and IIbeta in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique.
    Willmore E; Frank AJ; Padget K; Tilby MJ; Austin CA
    Mol Pharmacol; 1998 Jul; 54(1):78-85. PubMed ID: 9658192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of DNA topoisomerase IIalpha and beta in human leukaemia cells by immunoblotting.
    Padget K; Pearson AD; Austin CA
    Leukemia; 2000 Nov; 14(11):1997-2005. PubMed ID: 11069037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
    Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP; Brown GA; Goldenberg GJ
    Cancer Res; 1993 Dec; 53(24):5885-9. PubMed ID: 8261398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome.
    Schrader C; Meusers P; Brittinger G; Teymoortash A; Siebmann JU; Janssen D; Parwaresch R; Tiemann M
    Leukemia; 2004 Jul; 18(7):1200-6. PubMed ID: 15116121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered expression of DNA-topoisomerase IIalpha is associated with increased rate of spontaneous polyploidization in etoposide resistant K562 cells.
    Melixetian MB; Beryozkina EV; Pavlenko MA; Grinchuk TM
    Leuk Res; 2000 Oct; 24(10):831-7. PubMed ID: 10996201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells.
    Hong Y; Sang M; Shang C; Xue YX; Liu YH
    Neurosci Lett; 2012 Jun; 518(2):138-43. PubMed ID: 22569122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topoisomerase II-alpha expression in melanocytic nevi and malignant melanoma.
    Mu XC; Tran TA; Ross JS; Carlson JA
    J Cutan Pathol; 2000 May; 27(5):242-8. PubMed ID: 10847549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of DNA topoisomerase IIalpha in thyroid neoplasia.
    Lee A; LiVolsi VA; Baloch ZW
    Mod Pathol; 2000 Apr; 13(4):396-400. PubMed ID: 10786805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
    Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
    Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.